Screening compound: InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3

Screening compound: InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3
Screening compound: InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S624-0209

Molecular Formula

C16H21N3 (C16 H21 N3)

Compound Name

2'-methyl-2',3',4',9'-tetrahydrospiro[piperidine-4,1'-pyrido[3,4-b]indole]

IUPAC name

2'-methyl-2'3'4'9'-tetrahydrospiro[piperidine-41'-pyrido[34-b]indole]

SMILES

CN(CC1)C2(CCNCC2)c2c1c(cccc1)c1[nH]2

InChI

InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3

InChI Key

OEFMXBZDIIJNKY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28897757

InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3 in Drug Discovery

Included in Screening Libraries

3D-Fragment Library (4274 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

DGK Inhibitors Library (10558 compounds)

Natural-Product-Based Library (3730 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
  • Pool
  • Cyclic compounds
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3?
Check Price and Availability of InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C16H21N3/c1-19-11-6-13-12-4-2-3-5-14(12)18-15(13)16(19)7-9-17-10-8-16/h2-5,17-18H,6-11H2,1H3 available by request